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Cardiovascular disease (CVD) and type 2 diabetes (T2DM) are major contributors to the gap in life 
expectancy of Aboriginal peoples and Torres 
Strait Islanders (referred to as Indigenous for 
the purpose of this paper) relative to non-
Indigenous Australians.1,2 CVD is the primary 
cause of death in Indigenous people and the 
single largest determinant of the Indigenous 
health gap.1,2 Among Indigenous people, 
T2DM occurs at younger ages and with higher 
prevalence, and leads to mortality at 5.7 times 
the rate of other Australians.2-5 There has been 
no reduction in the mortality gap due to CVD 
and diabetes over the past decade.2
Modifiable metabolic risk factors (overweight 
and obesity, dyslipidaemia, hyperglycaemia, 
smoking and hypertension) may precede the 
onset of CVD by many years.6-9 Diabetes is a 
major risk factor for CVD, and frequently co-
exists with one or more modifiable metabolic 
risk factors in the same individual.
Disproportionately high rates of diabetes 
and CVD are seen in Indigenous Australians 
by the age of 35 years,3 highlighting the 
importance of early detection and treatment 
of risk factors and targeted preventive 
strategies in adolescence and early adulthood 
in Indigenous Australians.2,3,6 However, there 
is a paucity of data available on assessment 
of and follow-up of risk factors for CVD and 
T2DM in young (15–34 year old) Indigenous 
people.3,5,10-12
An important role of primary health care is 
to facilitate early detection, diagnosis and 
appropriate intervention for common and 
treatable conditions that cause significant 
and early morbidity and mortality.13 Tools 
designed to facilitate this preventive health 
care assessment of Indigenous Australians 
are referred to as ‘Well Person’s Checks’ and 
include the Medicare Benefit Schedule Item 
715 Annual Health Assessment for Aboriginal 
and Torres Strait Islander People14 and other 
alternate Adult Health Checks. Information 
on participation in these preventive health 
strategies for young Indigenous people 
is scarce, as is information on assessment 
of chronic disease risk factors when 
young people attend health care for other 
reasons. Continuous Quality Improvement 
(CQI) in Indigenous primary health care 
centres (PHCs) is emerging as an effective 
tool for enhancing the delivery of quality 
preventive health care.15-18 Information on 
current assessment practices regarding 
chronic disease risk factors can be used in 
the development of strategies to support 
PHCs to deliver preventive strategies for this 
population. 
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Abstract
Objective: To examine preventive health attendance and recording of type 2 diabetes and 
cardiovascular disease risk factors and their management in young Aboriginal peoples and 
Torres Strait Islanders (Indigenous Australians) at primary health care centres (PHCs).
Methods: This descriptive cross-sectional study audited medical records of 1,986 Indigenous 
people aged 15–34 years attending 93 Australian PHCs. Measurements included blood pressure 
(BP), blood glucose level (BGL), smoking status, body mass index (BMI) and lipid profile. 
Results: Last attendance was most commonly for acute care (46%); 12% attended for 
preventive assessment. BP was recorded in 85% (1,686/1,986), BGL 63% (1,244/1,986), smoking 
status 52% (1,033/1,986), BMI 37% (743/1,986) and lipids 31% (625/1,986). Of those with a 
recorded assessment, elevated BGL (39%, 479/1,244), smoking (63%, 649/1,033), overweight/
obesity (51%, 381/743) and dyslipidaemia (73%, 458/625) were common. Follow-up of 
abnormal results was documented for elevated BP 28% (34/120), elevated BGL 17% (79/479), 
smoking 65% (421/649), overweight/obesity 11% (40/381) and abnormal lipids 16% (75/458).
Conclusions: These findings highlight the importance of raising awareness and assessment of 
chronic disease risk factors in young Indigenous people and implementing preventive health 
care strategies.
Implications: Strengthening the capacity of PHCs to provide preventive health care may 
contribute to reducing the chronic disease burden experienced by young Indigenous people.
Key words: Indigenous, primary health care, Australia, quality improvement, cardiovascular 
disease, diabetes, prevention
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Objectives
This descriptive quantitative cross-sectional 
study examined the provision of preventive 
health care to young Indigenous people in 
PHCs around Australia, using a snapshot of 
data from a CQI initiative to determine what 
preventive health care young Indigenous 
people are receiving for CVD and T2DM.
Using clinical audit data, our objectives were 
to determine:
•	 the proportion of young Indigenous 
people attending for preventive health 
assessments 
•	 the frequency of assessment of risk factors 
for CVD and T2DM when young people 
present to PHCs
•	 the proportion of those assessed who have 
risk factors 
•	 what management is documented for 
identified risk factors. 
A subgroup analysis aimed to determine 
whether these factors are associated with 
individual or PHC characteristics. 
Methods
The data presented here were collected 
by the Audit and Best Practice for Chronic 
Disease (ABCD) National Research 
Partnership19 between 2010 and 2012, 
for which the study design, planning and 
implementation have been previously 
described.19,20 Participating PHCs were 
distributed in remote (n=79), regional (n=9) 
and urban (n=5) settings in Queensland 
(n=47), Northern Territory (n=35), South 
Australia (n=5), New South Wales (n=4) and 
Western Australia (n=2). Government PHCs 
(n=78) and Aboriginal Community-Controlled 
Health Services (community-controlled PHCs; 
n=15) participated.
Delivery of preventive health care was 
assessed by auditing health records from 
participating PHCs. Both paper-based and 
electronic clinical records were audited. 
Trained members of the project team 
conducted the audits in conjunction with 
local health care staff supported by a 
standard protocol, local CQI facilitators and 
regional CQI coordinators. The Preventive 
Services Clinical audit tool was generated 
based on best practice clinical guidelines,21,22 
and developed with stakeholder consultation. 
A random sample of at least 30 eligible 
records was selected by the auditor at each 
PHC using a standard sampling protocol.19 
PHCs with fewer than 30 eligible records 
audited those of all eligible clients.
Records eligible for auditing included those of 
adults aged between 15 and 54 years with no 
known diagnosis of diabetes, hypertension, 
coronary heart disease, rheumatic heart 
disease or renal disease. Patients included 
had been living in the community for at least 
six months in the past year. Women who were 
pregnant or up to six weeks postpartum at 
the time of the audit were excluded.
Data examined included patient and PHC 
characteristics, (location, governance 
structure [government or community 
controlled], state/territory), the date and 
reason for the last attendance, record of 
assessment, presence and management of 
risk factors for CVD and T2DM. Assessment of 
risk factors was measured as documentation 
of blood pressure (BP), blood glucose level 
(BGL), smoking status (current smoker/non-
smoker/not-stated), body mass index (BMI), 
and lipid profile21 in the medical record. These 
could be collected either as part of a routine/
acute health consultation, or as a part of a 
preventive health assessment.23
The presence of risk factors for CVD and T2DM 
were defined as overweight/obese as indicated 
by BMI (≥25 kg/m2);24 elevated random or 
fasting BGL (BGL≥5.5 mmol/L); abnormal lipid 
profile (low density lipoprotein≥2.5 mmol/L, 
triglycerides≥1.5 mmol/L, and/or high density 
lipoprotein<1.0 mmol/L); current smoking; and 
hypertension (BP≥140/90), as audited from the 
medical record.21
Follow-up was measured as documentation of:
•	 hypertension: a management plan 
including repeat BP testing
•	 elevated BGL: a management plan 
including repeat glucose testing
•	 smoking: brief intervention including 
documentation of intention or interest in 
quitting
•	 overweight/obesity: a brief intervention 
where the client had been asked about 
their weight and their intentions or interest 
in reducing weight, and a referral for 
weight management advice/support
•	 abnormal lipid profile: a management plan 
including repeat blood lipids testing.21,22
The study was approved by human research 
ethics committees in the relevant state or 
territory and by Indigenous sub-committees 
where required.25 The analyses presented 
here were approved by Monash University 
and James Cook University Human Research 
Ethics Committees (CF12/3434-2012001670 
and CF12/3434 – 2012001670). 
Statistical analysis
Categorical variables are presented as 
count and proportions. Continuous data are 
reported as mean and standard deviation, 
or median and interquartile range (IQR) 
where data is not normally distributed. 
Subgroup comparative analysis of nominal 
values was undertaken using chi-squared 
tests for age, sex, Indigenous status, location 
and governance structure (government or 
community controlled) of PHCs. A p-value 
less than 0.05 was considered statistically 
significant. Statistical analysis used Stata 12.1.
Results
Patient and health centre 
characteristics
Audit data were obtained from PHCs for 4,536 
young people (15 to 34 years). Where PHCs 
had undergone more than one audit during 
the study period 2010 to 2012, only data 
from the most recent audit were included to 
avoid repeat counting from the same service, 
resulting in the exclusion of 1,878 records. A 
further 478 records were excluded if people 
did not identify as Aboriginal and/or Torres 
Strait Islander and 192 records were excluded 
as they were seen more than 24 months prior 
to the audit. Two were excluded where the 
date of auditing was documented as earlier 
than the date last seen.
Audit data were obtained for the remaining 
1,986 young Indigenous people from 
93 participating PHCs. Patient and PHC 
characteristics are shown in Table 1. Acute 
care was the reason for the most recent 
presentation in 46% of audited patients, 
while 12% presented for preventive health 
assessment (a ‘Well Person’s Check’, Figure 
1). One patient did not have a reason 
for last attendance recorded. In 30% of 
audited records, there was evidence of a 
standardised comprehensive annual adult 
health assessment for Aboriginal and Torres 
Strait Islander People form (Medicare Benefits 
Schedule 71514), or alternative, having been 
conducted in the past two years (Table 1).
Most subjects were audited in remote (80%, 
1,578/1,986) and government-operated 
(82%, 1,628/1,986) PHCs, although a range 
of locations and governance structures were 
represented (Table 1).
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Assessment of CVD and T2DM risk 
factors
The majority of audited patients had record of 
BP (85%, 1,686/1,986), BGL (63%,1,244/1,986) 
and smoking status (52%, 1,033/1,986) 
(Figure 2). Assessment of BMI and lipids 
was less frequent (37%, 743/1,986 and 31%, 
625/1,986, respectively) (Figure 2). Patients 
aged 25 to 34 years were significantly more 
likely to be assessed for risk factors than those 
aged 15 to 24 years, with the exception of 
BMI measurement (BP: 87% vs 84%, p=0.04; 
BGL: 70% vs 58%, p<0.001; smoking: 58% vs 
48%, p<0.001; lipids: 39% vs 26%, p<0.001) 
(Table 2). Women were more likely to have 
a record of BP, BGL and smoking status than 
men (BP: 88% vs 82%, p<0.001; BGL: 68% vs 
58%, p<0.001; smoking: 55% vs 50%, p=0.03) 
(Table 2). Smoking status and BMI were more 
likely to be recorded in community controlled 
PHCs. Those in remote communities were less 
likely to have a record of BP, smoking status 
and BMI assessment, but more likely to have 
a recorded lipid profile (Table 3). Variations in 
assessment were noted across jurisdictions 
(state/territory) but no consistent pattern was 
observed.
Presence of CVD and T2DM risk factors
The presence of risk factors was high in those 
who had a record of assessment, with the 
exception of BP (BP: 7%; BGL: 39%; smoking: 
63%; BMI: 51%; lipids: 73%) (Table 2 and 
Figure 2). Patients aged 25 to 34 years who 
were assessed had a significantly higher 
presence of hypertension, overweight/
obesity and abnormal lipid profile than 
those aged 15–24 years (9% vs 6%, p=0.01; 
65% vs 41%, p<0.001; 81% vs 66%, p<0.001; 
respectively) (Table 2). A significantly 
higher proportion of women were in the 
overweight/obese category than men (59% 
vs 44%, p<0.001); however, men were more 
likely to be hypertensive than women (10% vs 
4%, p<0.001) (Table 2).
Follow-up of identified risk factors for 
CVD and T2DM
Among those with abnormal findings, 
documented follow-up was infrequent with 
the exception of current smokers (BP 28%; 
BGL 17%; smoking 65%; BMI 11%; lipids 16%) 
(Figure 2 and Table 2). A lipid management 
plan was more likely in the older group (20% 
vs 12%, p=0.03) (Table 2). Brief interventions 
(BI) for smoking and overweight/obesity 
and follow-up of abnormal lipid profile were 
more likely in urban than regional or remote 
Table 1: Characteristics of young Indigenous people (n=1986) whose records were audited.
Characteristic Total n (%)
Patient age Patient gender
15-24 n (%) 25-34 n (%) Male n (%) Female n (%)
n (%) 1986 1163 (59) 823 (41) 984 (50) 1002 (51)
BMI median (± IQR) 25 (10) 23 (9) 28 (10) 24 (9) 27 (11)
MBS Item 715 or alternate in last two years 599 (30) 344 (30) 255 (31) 321 (33) 278 (28)
Indigenous status
 Aboriginal
 Torres Strait Islander
 Both
1414 (71)
471 (24)
101 (5)
836 (72)
255 (22)
72 (6)
578 (70)
216 (26)
29 (4)
695 (70)
243 (25)
46 (5)
719 (72)
228 (23)
55 (5)
PHC location
 Urban (>25,000 people)
 Regional (<25,000 people)
 Remote (>10km from a regional town)
160 (8)
248 (13)
1578 (80)
130 (11)
150 (13)
883 (76)
30 (4)
98 (12)
695 (85)
96 (10)
124 (13)
764 (78)
64 (6)
124 (12)
814 (81)
PHC Governance 
 Community Controlled
 Government Operated
358 (18)
1628 (82)
204 (18)
959 (83)
154 (19)
669 (81)
173 (18)
811 (82)
185 (19)
817 (82)
PHC State/Territory
 Queensland
 Northern Territory
 South Australia
 New South Wales
 Western Australia
951 (48)
780 (39)
125 (6)
91 (5)
39 (2)
577 (50)
432 (37)
78 (7)
53 (5)
23 (2)
374 (45)
348 (42)
47 (6)
38 (5)
16 (2)
464 (47)
387 (39)
76 (8)
41 (4)
16 (2)
487 (49)
393 (39)
49 (5)
50 (5)
23 (2)
Figure 1: Frequency of reason for most recent attendance to PHC stratified by age and gender (n=1986).
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Table 2: Documented risk factor assessment, prevalence and follow-up of abnormal findings stratified by gender and age.
Risk Factor Total n (%)
Gender Age
Males n (%) Females n (%) p-value 15-24 years n (%) 25-34 years n (%) p-value
BP
 BP Recorded
 BP Elevated
 BP Management Plan
1686/1986 (85)
120/1686 (7)
34/120 (28)
805/984 (82)
82/805 (10)
22/82 (27)
881/1002 (88)
38/881 (4)
12/38 (32)
<0.001
<0.001
0.59
971/1163 (84)
55/971 (6)
15/55 (27)
715/823 (87)
65/715 (9)
19/65 (29)
0.04
0.01
0.81
BGL
 BGL Recorded
 Elevated BGL
 BGL Management Plan
1244/1986 (63)
479/1244 (39)
79/479 (17)
566/984 (58)
205/566 (36)
37/205 (18)
678/1002 (68)
274/678 (40)
42/274 (15)
<0.001
0.13
0.43
670/1163 (58)
254/670 (38)
36/254 (14)
574/823 (70)
225/574 (39)
43/225 (19)
<0.001
0.64
0.15
Smoking
 Smoking Status Recorded
 Current Smoker 
 Smoking Brief Intervention
1033/1986 (52)
649/1033 (63)
421/649 (65)
487/984 (50)
320/487 (66)
216/320 (68)
546/1002 (55)
329/546 (60)
205/329 (62)
0.03
0.07
0.17
558/1163 (48)
346/558 (62)
227/346 (66)
475/823 (58)
303/475 (64)
194/303 (64)
<0.001
0.56
0.67
BMI
 BMI Recorded
 Overweight/Obese 
 Brief Intervention 
 Weight Management Referral
743/1986 (37)
381/743 (51)
157/381 (41)
40/381 (11)
381/984 (39)
169/381 (44)
69/169 (41)
13/169 (8)
362/1002 (36)
212/362 (59)
88/212 (42)
27/212 (13)
0.23
<0.001
0.89
0.11
427/1163 (37)
175/427 (41)
71/175 (41)
14/175 (8)
316/823 (38)
206/316 (65)
86/206 (42)
26/206 (13)
0.45
<0.001
0.82
0.14
Lipids
 Lipid Profile
 Abnormal Lipid Profile
 Lipid Management Plan
625/1986 (31)
458/625 (73)
75/458 (16)
319/984 (32)
242/319 (76)
44/242 (18)
306/1002 (31)
216/306 (71)
31/216 (14)
0.37
0.14
0.27
305/1163 (26)
200/305 (66)
24/200 (12)
320/823 (39)
258/320 (81)
51/258 (20)
<0.001
<0.001
0.03
settings (smoking BI: 79% vs 59% vs 64%, 
p=0.01; overweight/obesity BI: 60% vs 26% 
vs 42%, p=0.001; lipid follow-up: 33% vs 
3% vs 17% p=0.02) (see Table 3). Variations 
across jurisdictions were noted but were not 
uniform for each risk factor.
Conclusions
This unique, large, national study 
investigating provision of preventive health 
care for cardiovascular and diabetes risk 
in young Indigenous people shows that 
while risk factors are being assessed, there is 
opportunity to engage with PHCs to improve 
their capacity to provide effective preventive 
care for young people. Although acute care is 
the most common reason for this population 
to present to PHCs, the majority receive an 
assessment of risk factors for CVD and T2DM 
(BP, BGL, smoking). Despite the young age of 
the survey population, those who received 
assessment were commonly found to have 
important modifiable risk factors for chronic 
disease. However, follow-up of abnormal 
results was undertaken less thoroughly. Early 
assessment is important as it provides an 
opportunity for prevention, early detection 
and mitigation of metabolic disease in a 
group of people at increased risk. The current 
national guidelines on preventive health 
assessment recommend screening young 
Indigenous people for chronic disease risk 
factors in an annual health assessment and 
opportunistically.26 Preventive health care 
recommendations include measurement 
of BP and assessment of diabetes risk in all 
Indigenous people over 15 years of age, with 
record of smoking status and BMI in all those 
aged over 12 years.21,22 Lipid profile should 
be assessed if an additional cardiovascular 
risk factor is present.21,22 Other research 
assessing cardiovascular risk in Indigenous 
adults in PHCs has reported that more than 
half of patients aged over 30 years were not 
adequately screened.27 Our study contributes 
new knowledge to this area by focussing on a 
younger population and highlights that some 
areas of risk are assessed relatively well (BP, 
BGL, smoking status) and other aspects (BMI, 
lipids, assessing men, people aged 15–24, 
those in remote locations) are areas where 
service provision could be strengthened. 
Almost one-third had a record of attending 
for a comprehensive annual primary health 
care review in the previous two years. How 
this compares to other populations is difficult 
to gauge, due to a lack of comparable 
estimates. 
Acute care was the primary reason for most 
recent attendance, while few attended for 
preventive health care assessment. This is 
consistent with a case-finding approach, in 
which people undergoing medical care are 
assessed for asymptomatic diseases and risk 
factors, rather than systematic population 
screening, where an asymptomatic 
population are assessed to identify a 
subgroup of people at high risk of a disease 
or a risk factor for a disease.28 This suggests 
a need to support PHCs to strengthen 
delivery of preventive health care services at 
a population level through strategies such 
as strengthening financial and workforce 
support to PHCs to facilitate screening 
programs; supporting efforts to enhance 
documentation and undertake assessment 
and follow-up of CVD and T2DM risk factors 
in line with best practice clinical guidelines; 
using reminder systems to encourage patient 
attendance and follow-up of abnormal 
findings; and continuing the implementation 
of CQI processes.29
The potential for selection bias through 
patterns of attendance and screening 
practices mean the data presented may 
not be an accurate reflection of population 
prevalence. The data indicate that risk factor 
assessment is being targeted appropriately 
to patients who are clinically identified as 
high risk. Despite this, the high prevalence 
of smoking and obesity are consistent with 
other recent reports.30-33 Obesity is a key risk 
factor for T2DM and CVDs: hypertension, 
stroke and coronary artery disease.33 Half 
of all patients audited were overweight/
obese and, while these proportions are 
similar to the general Australian population,34 
elevated BMI is a stronger risk factor for 
464 Australian and New Zealand Journal of Public Health 2017 vol. 41 no. 5
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T2DM in Indigenous than non-Indigenous 
people.30,33,35 While overweight/obesity was 
considerably more common in the 25 to 
34-year age group, this may not represent a 
true difference in prevalence, but may instead 
represent variation in the selection of those 
for BMI assessment. A potential hypothesis 
is that patients in the younger age group 
may be less likely to attend, or may be less 
likely to be weighed, if they appear obese as 
they may be considered to be at relatively 
lower risk of CVD. Despite this, the high 
levels of overweight/obesity seen in young 
Indigenous women is of major concern, given 
that maternal obesity increases pregnancy-
related risks for the mother and baby, and 
increases the child’s risk of future obesity, 
diabetes and CVD.4,36 Further assessment for 
T2DM was required in 41% of patients, based 
on a random or fasting BGL ≥5.5 mmol/L. 
Given this low glucose cut-off, it is difficult 
to make comparisons to the prevalence of 
T2DM risk identified in other studies, where 
the prevalence of T2DM in Indigenous adults 
ranges from 3–33% and IGT 4.7–22%, with 
patterns suggesting higher risks in women 
and in remote areas.6
This study is inherently limited by its 
retrospective, cross-sectional nature; 
however, this is the design of CQI projects, 
which analyse existing data in a cyclical 
fashion to improve processes.37 We rely 
on accurate documentation of health care 
Table 3: Documented screening, prevalence and follow-up of abnormal findings stratified by governance structure and location.
Risk Factor
Community 
controlled n (%)
Government 
operated n (%)
p-value Urban n (%) Regional n (%) Remote n (%) p-value
BP
 BP recorded
 BP elevated
 BP management plan
313/358 (87)
37/313 (12)
6/37 (16)
1,373/1,628 (84)
83/1,373 (6)
28/83 (34)
0.14
<0.001
0.05
142/160 (89)
7/142 (5)
1/7 (14)
223/248 (90)
19/223 (9)
3/19 (16)
1,321/1,578 (84)
94/1321 (7)
30/94 (32)
0.02
0.43
0.33
BGL
 BGL recorded
 Elevated BGL
 BGL management plan
207/358 (58)
98/207 (47)
19/98 (19)
1,037/1,628 (64)
381/1,037 (37)
60/381 (16)
0.04
0.004
0.39
90/160 (56)
38/90 (42)
10/38 (26)
149/248 (60)
74/149 (50)
7/74 (9)
1,005/1,578 (64)
367/1005 (37)
62/367 (17)
0.12
0.01
0.07
Smoking
 Smoking status recorded
 Current smoker 
 Smoking brief intervention
224/358 (63)
157/224 (70)
97/157 (62)
809/1628 (50)
492/809 (61)
324/492 (66)
<0.001
0.01
0.35
125/160 (78)
85/125 (68)
67/85 (79)
151/248 (61)
95/151 (63)
56/95 (59)
757/1578 (48)
469/757 (62)
298/469 (64)
<0.001
0.43
0.01
BMI
 BMI recorded
 Overweight/obese 
 Brief intervention 
 Weight management referral
180/358 (50)
89/180 (49)
31/89 (35)
10/89 (11)
563/1628 (35)
292/563 (52)
126/292 (43)
30/292 (10)
<0.001
0.10
0.16
0.80
98/160 (61)
43/98 (44)
26/43 (60)
8/43 (19)
124/248 (50)
69/124 (56)
18/69 (26)
7/69 (10)
521/1578 (33)
269/521 (52)
113/269 (42)
25/269 (9)
<0.001
0.50
0.001
0.19
Lipids
 Lipid profile
 Abnormal lipid profile
 Lipid management plan
114/358 (32)
86/114 (75)
9/86 (10)
511/1628 (31)
372/511 (73)
66/372 (18)
0.87
0.57
0.10
16/160 (10)
12/16 (75)
4/12 (33)
46/248 (19)
35/46 (76)
1/35 (3)
563/1578 (36)
411/563 (73)
70/411 (17)
<0.001
0.94
0.02
provision as a measure of preventive health 
care. Failure to document services may lead 
to an underestimation of service provision; 
however, failure of documentation itself is 
a barrier to quality preventive care.25 Data 
around follow-up appeared to be the most 
affected by such quality issues. Given that 
acute care was the most frequent reason for 
last attendance, we consider it possible that 
BP, BGL or lipid profile measured during those 
presentations were affected by the acute 
condition, potentially leading to an over-
estimation of the prevalence of abnormal 
results. Hypertension, overweight/obesity 
and abnormal lipid profile were categorised 
by adult values, even in those aged 15–18 
years; however, if anything, this is likely to 
lead to an underestimation of the prevalence 
in this young population. Chi-squared tests 
have been used to conduct exploratory 
analysis of associations between service 
delivery and potential predictors (age, 
gender, location, governance structure); 
however, we acknowledge that these do not 
take into account the possible contributions 
of multiple variables. Quantifying the 
magnitude of associations would be an 
important future direction for this ongoing 
CQI initiative, as sample size increases.
This is the largest and most comprehensive 
study of primary health care provision for 
risk factors for CVD and T2DM experienced 
by young Indigenous people, and spans 
remote, rural and urban populations. 
This community controlled and directed 
project was conducted as a part of a 
research partnership with a commitment 
to translation of research into effective 
change. The findings of this study fill gaps 
in knowledge about preventive health care 
provision to young Indigenous people, 
and may be used to enhance Indigenous 
primary health care.
These findings can be used to inform 
improvements in public health practices, 
and highlight the importance of support 
for the implementation of targeted 
preventive health care strategies, which 
may reduce the burden of CVD and 
T2DM experienced by young Indigenous 
people and improve long-term health. 
At completion of the Preventive Health 
Clinical Audit, CQI facilitators assisted 
local PHCs with interpretation of the 
data, feedback to health care providers 
and management, goal setting and 
action planning.19 Individual PHCs then 
independently implemented their action 
plan to inform enhancements in health care 
services, systems and policy.19 Nationally, 
the aggregated findings presented in this 
paper were presented to a broad range of 
stakeholders at the annual ABCD National 
Research Partnership meeting. Evidence 
briefs are also prepared to communicate key 
findings and messages for action to health 
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workers and community health boards. 
During this feedback process, concerns were 
raised by health care workers that increased 
efforts to incorporate screening during acute 
care consultations may jeopardise the fragile 
relationship they have with young people 
and discourage them from returning to the 
PHC. Another concern among health care 
workers was that there is a lack of effective 
evidence-based management programs or 
guidelines to facilitate follow-up. This may 
contribute to both reduced screening and 
provision of follow-up, which is likely to be 
particularly relevant in remote locations, 
where assessment was found to be least 
frequent. 
Examining documentation of follow-up 
identifies areas where PHC systems and 
processes could be strengthened to support 
health professionals to provide these aspects 
of preventive care. Lack of follow-up may 
relate to the use of case-finding rather than 
participation in screening programs that 
ensure systematic follow-up of abnormal 
findings. Comprehensive cardiovascular risk 
assessment during a dedicated Adult Health 
Check has been found to be an effective way 
to increase early identification of elevated 
cardiovascular risk and improve provision 
of preventive care services in Indigenous 
adults.38,39 This may offer an opportunity to 
increase preventive health care provision 
and improve follow-up without imposing on 
acute care. 
The need for culturally appropriate training 
for health workers in screening, assessment, 
treatment and referral is a key finding of 
the ABCD National Research Partnership 
project.29 As discussed above, health care 
workers request development and promotion 
of evidence-based management programs 
or guidelines to facilitate follow-up. Future 
research directions may include examining 
barriers to health services attendance for 
assessment and follow-up through focus 
groups involving young Indigenous people. 
The results from this study were obtained 
from PHCs participating in a large-scale CQI 
initiative across a broad range of settings 
and, as such, the findings are to some extent 
generalisable to PHCs providing care to the 
wider young Indigenous population across 
Australia. We anticipate that the limitations 
in preventive health care provision identified 
are system-level issues, on which PHCs may 
choose to focus their quality improvement 
activities, to strengthen health care practices 
and improve delivery of preventive health 
care.37,40 System-wide quality improvement 
is an effective method to strengthen health 
systems and enhance provision of quality 
care.41 Primary health care networks and 
partnership-based approaches to quality 
improvement, such as the ABCD National 
Research Partnership, can be used to 
strengthen quality of primary health care to 
address inequitable levels of chronic disease 
experienced by Indigenous people.42,43
The high frequency of risk factors for CVD 
and T2DM evident by the age of 15 years, the 
age gradient in overweight/obesity and the 
lipid profile seen in our study, indicate that 
primary preventive health care should target 
Aboriginal and Torres Strait Islander people 
in early life. Programs aimed at adolescents, 
children, babies and mothers are required to 
circumvent development of these risk factors 
before the age of 15 years.
Implications
An appreciation of the importance of 
preventive health care provision to young 
Indigenous people in PHCs is highlighted by 
the frequency of assessment demonstrated in 
this study. The high presence of risk factors for 
CVD and T2DM in young Indigenous people, 
and the low frequency of documented follow-
up when these are identified, have important 
public health implications for Australia. 
Improvements in effective management tools 
to facilitate follow-up may strengthen the 
capacity of PHCs to provide crucial preventive 
health care to reduce the burden of chronic 
disease experienced by young Indigenous 
people. Such programs need to be driven by 
health centres and communities, and a CQI 
framework is a successful strategy that could 
be employed to facilitate this. 
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